Long-term survival outcomes associated with robotic-assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer

被引:7
|
作者
Byiringiro, Innocent [1 ]
Aurit, Sarah J. [2 ]
Nandipati, Kalyana C. [3 ]
机构
[1] Creighton Univ, Sch Med, Dept Surg, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Med Clin Res & Evaluat Sci, Omaha, NE USA
[3] Creighton Sch Med, Esophageal Ctr, Dept Surg, 7710 Mercy Rd,Suite 501, Omaha, NE 68124 USA
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2023年 / 37卷 / 05期
关键词
Esophagectomy; RAMIE; MIS; Esophageal Cancer; Robotic Surgery; CHEMORADIOTHERAPY;
D O I
10.1007/s00464-022-09588-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Minimally Invasive esophagectomy for esophageal cancer is associated with less morbidity compared to open approach. Whether robotic-assisted minimally invasive esophagectomy (RAMIE) results in better long-term survival compared with open esophagectomy (OE) and minimally invasive esophagectomy (MIE) is unclear. Methods We analyzed data from the National Cancer Database (NCDB) for patients with primary esophageal cancers who underwent esophagectomy in 2010-2017. Those with unknown staging, distant metastasis, or diagnosed with another cancer were excluded. Patients were stratified by RAMIE, MIE, and OE operative techniques. The Kaplan-Meier method and associated log-rank test were employed to compare unadjusted survival outcomes by surgical technique, our primary outcome. Multivariable Cox proportional hazards regression model was employed to discern factors independently contributing to survival. Results A total of 5170 patients who underwent esophagectomy were included in the analysis; 428 underwent RAMIE, 1417 underwent MIE, and 3325 underwent OE. Overall median survival was 42 months. In comparison to RAMIE, there was an increased risk of death for those that underwent either MIE [Hazard Ratio (HR) = 1.19; 95% Confidence Interval (CI): > 1.00 to 1.41; P < 0.047)] or OE (HR =1.22; 95% CI: 1.04 to 1.43; P < 0.017). Academic vs community program facility type was associated with decreased risk of death (HR= 0.84; 95% CI: 0.76 to 0.93; P < 0.001). In general, males from areas of lower income with advanced stages of cancer who received neoadjuvant chemotherapy or radiation were at increased risk of death. Factors that were not associated with survival included race and ethnicity, Charlson-Devo Score, type of health insurance, zipcode level education, and population density. Conclusions Overall survival was significantly longer in patients with esophageal cancers that underwent RAMIE in comparison to either MIE or OE in a 7-year NCDB cohort study. [GRAPHICS] .
引用
收藏
页码:4018 / 4027
页数:10
相关论文
共 50 条
  • [41] Long-term outcomes of robot-assisted versus minimally invasive esophagectomy in patients with thoracic esophageal cancer: a propensity score-matched study
    Sakurai, Toru
    Hoshino, Akihiro
    Miyoshi, Kenta
    Yamada, Erika
    Enomoto, Masaya
    Mazaki, Junichi
    Kuwabara, Hiroshi
    Iwasaki, Kenichi
    Ota, Yoshihiro
    Tachibana, Shingo
    Hayashi, Yutaka
    Ishizaki, Tetsuo
    Nagakawa, Yuichi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [42] Postoperative Pneumonia is Associated with Long-Term Oncologic Outcomes of Definitive Chemoradiotherapy Followed by Salvage Esophagectomy for Esophageal Cancer
    Masashi Takeuchi
    Hirofumi Kawakubo
    Shuhei Mayanagi
    Kayo Yoshida
    Kazumasa Fukuda
    Rieko Nakamura
    Koichi Suda
    Norihito Wada
    Hiroya Takeuchi
    Yuko Kitagawa
    Journal of Gastrointestinal Surgery, 2018, 22 : 1881 - 1889
  • [43] Outcomes of robotic versus non-robotic minimally-invasive esophagectomy for esophageal cancer: An American College of Surgeons NSQIP database analysis
    Harbison, Gregory J.
    Vossler, John D.
    Yim, Nicholas H.
    Murayama, Kenric M.
    AMERICAN JOURNAL OF SURGERY, 2019, 218 (06) : 1223 - 1228
  • [44] Comparison of complications and long-term survival after minimally invasive esophagectomy versus open esophagectomy in patients with esophageal cancer and chronic obstructive pulmonary disease
    Rong, Yu
    Hao, Yanbing
    Xue, Jun
    Li, Xiaoyuan
    Li, Qian
    Wang, Li
    Li, Tian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Long-term outcomes following minimally invasive and open esophagectomy in Finland: A population-based study
    Sihvo, Eero
    Helminen, Olli
    Gunn, Jarmo
    Sipila, Jussi O. T.
    Rautava, Paivi
    Kyto, Ville
    EJSO, 2019, 45 (06): : 1099 - 1104
  • [46] Minimally invasive and robotic-assisted surgical management of upper gastrointestinal cancer
    Grimminger, P. P.
    Fuchs, H. F.
    CHIRURG, 2017, 88 (12): : 1017 - 1023
  • [47] Long-term oncological outcomes following completely minimally invasive esophagectomy versus open esophagectomy
    Patel, K.
    Askari, A.
    Moorthy, K.
    DISEASES OF THE ESOPHAGUS, 2020, 33 (06)
  • [48] Robotic-Assisted Ivor Lewis Esophagectomy Is Safe and Cost Equivalent Compared to Minimally Invasive Esophagectomy in a Tertiary Referral Center
    Knitter, Sebastian
    Maurer, Max M.
    Winter, Axel
    Dobrindt, Eva M.
    Seika, Philippa
    Ritschl, Paul V.
    Raakow, Jonas
    Pratschke, Johann
    Denecke, Christian
    CANCERS, 2024, 16 (01)
  • [49] Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer
    Nomoto, Daichi
    Yoshida, Naoya
    Akiyama, Takahiko
    Kiyozumi, Yuki
    Eto, Kojiro
    Hiyoshi, Yukiharu
    Nagai, Yohei
    Iwatsuki, Masaaki
    Iwagami, Shiro
    Baba, Yoshifumi
    Miyamoto, Yuji
    Baba, Hideo
    ANTICANCER RESEARCH, 2019, 39 (01) : 471 - 475
  • [50] Minimally Invasive Versus Open Ivor-Lewis Esophagectomy for Esophageal Cancer or Cancer of the Gastroesophageal Junction: Comparison of Postoperative Outcomes and Long-term Survival Using Propensity Score Matching Analysis
    Knitter, Sebastin
    Andreou, Andreas
    Hofmann, Tobias
    Chopra, Sascha
    Denecke, Christian
    Thuss-patience, Peter C.
    Kroll, Dino
    Bahra, Marcus
    Schmelzle, Moritz
    Pratschke, Johann
    Biebl, Matthias
    ANTICANCER RESEARCH, 2021, 41 (07) : 3499 - 3510